Aging of the brain is characterized by deleterious processes at various levels including cellular/molecular and ...

Lu]Lu-PSMA-617 radiopharmaceutical therapy has been approved for the treatment of men with metastatic castration-resistant ...

Prostate-specific membrane antigen (PSMA) is a promising target in prostate cancer. Recently, we started the first-in-human treatment with an α-radionuclide–labeled PSMA ligand. Although the case ...

The deployment of artificial intelligence (AI) has the potential to make nuclear medicine and medical imaging faster, cheaper, and both more effective and more accessible. This is possible, however, ...

Journal of Nuclear Medicine October 2025, jnumed.125.270804; DOI: https://doi.org/10.2967/jnumed.125.270804 ...

This paper presents standardized methods for performing dose calculations for radiopharmaceuticals. Various steps in the process are outlined, with some specific examples given. Special models for ...

Auger electron emitters such as 125I have a high linear energy transfer and short range of emission (<10 μm), making them suitable for treating micrometastases while sparing normal tissues. We used a ...

Journal of Nuclear Medicine August 2025, jnumed.125.270317; DOI: https://doi.org/10.2967/jnumed.125.270317 ...

Journal of Nuclear Medicine September 2025, jnumed.125.270267; DOI: https://doi.org/10.2967/jnumed.125.270267 ...

Journal of Nuclear Medicine October 2025, jnumed.125.269840; DOI: https://doi.org/10.2967/jnumed.125.269840 ...

Irène Buvat, PhD, Centre National de la Recherche Scientifique director of research and head of the Inserm Laboratory of Translational Imaging in Oncology at the Institut Curie, Orsay (France), and ...

Despite significant advancements in medical and device-based therapies, cardiovascular disease remains the number one cause of death in the United States. Early detection of atherosclerosis, ...